Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Shandong Weigao Group Medical Polymer Co ( (HK:1066) ) just unveiled an update.
Shandong Weigao Group Medical Polymer Company Limited held an Extraordinary General Meeting on October 17, 2025, where all proposed resolutions were approved by shareholders. Key decisions included the approval of the 2025 H Share Incentive Scheme, the distribution of an interim dividend, and several amendments to the company’s articles of association. These resolutions are expected to enhance shareholder value and align the company’s governance structure with its strategic goals.
The most recent analyst rating on (HK:1066) stock is a Hold with a HK$6.50 price target. To see the full list of analyst forecasts on Shandong Weigao Group Medical Polymer Co stock, see the HK:1066 Stock Forecast page.
More about Shandong Weigao Group Medical Polymer Co
Shandong Weigao Group Medical Polymer Company Limited is a joint stock limited company incorporated in the People’s Republic of China. The company operates in the medical industry, focusing on the production of medical polymer products.
Average Trading Volume: 15,985,716
Technical Sentiment Signal: Sell
Current Market Cap: HK$25.78B
Learn more about 1066 stock on TipRanks’ Stock Analysis page.